In this presentation from the Treatment Dilemmas in Polycythemia Vera: Leveraging Evidence and Clinical Experience to Improve Patient Care symposium, Dr. Elizabeth O. Hexner discusses when to move from hydroxyurea to a second-line therapy.
Earn CME Credit for this activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=7261
© 2017 Imedex, LLC.